A Few Words,
Made Clear.

How to Use This CBD Glossary

You may encounter several kinds of language on the same page: plant names, ingredient descriptions, package units, laboratory terms, and clinical-research methods. They answer different questions. A spectrum term describes a claimed mixture. A concentration describes an amount per unit. A trial result describes a particular comparison. Learning the difference makes the rest of an article easier to follow.

Search for the term that interrupts your reading, then return to the sentence where you found it. Ask what the writer is using the term to establish. Does it identify an ingredient, report a measurement, or suggest a clinical conclusion? The definition can clarify the first two while showing why the third may need additional evidence.

These entries use everyday language and practical distinctions. They are not a substitute for the detailed definitions in a specific study, laboratory method, policy, or law. When a decision depends on precision, read that document’s definition too. A useful glossary helps you identify the information you need rather than pretending every context uses identical wording.

Which Words Describe a Product, and Which Describe Evidence?

CBD, carrier oil, extract, full-spectrum, and isolate help describe composition or processing. They do not, by themselves, establish a product’s clinical effectiveness. The FDA explains the difference between its approved prescription CBD medicine and other CBD products marketed with therapeutic claims.[3] Keep the ingredient and the evidence as separate parts of the question.

Laboratory terms such as concentration, batch number, and not detected help you read measurements. NIST’s cannabis measurement work illustrates the importance of reliable measurement methods and reference materials.[1] A method can support a numerical result while leaving clinical benefit outside its purpose.

Research words such as randomized, placebo, primary outcome, and observational help identify a study’s design. Use them to ask how the comparison was made and what finding the design can support. A well-defined word provides a starting point; the actual methods and results complete the explanation.

Read an Illustrative Label Without Choosing a Dose

Imagine a fictional label stating 900 mg CBD in a 30 mL bottle, with a listed serving of 0.5 mL. The total amount is 900 mg. The listed concentration is 30 mg per mL. The listed serving amount is 15 mg. These are three descriptions of the same label figures, each answering a different quantity question.

Now imagine that the front says only “900 mg hemp extract.” That wording does not state that all 900 mg is CBD. You would need the quantitative cannabinoid information to calculate a CBD concentration. The complete ingredient list may also describe a carrier oil, which is a separate ingredient.

The arithmetic does not verify the label or identify a suitable personal exposure. Use the label guide for more examples and the report guide for the actual measurement questions. The FDA’s safety information explains why health history and interactions need a separate professional assessment.[2]

Keep the Definition With Its Context

A term can be familiar while its use in a particular document is narrower than expected. A laboratory’s reporting threshold, a study’s primary outcome, and a legal definition of hemp each need the applicable document. Write down the term, the definition provided there, and the date when it matters.

For scientific background, the endocannabinoid-system review explains signaling terminology, while the purified-CBD pharmacokinetic study provides examples of exposure and food-effect concepts.[5][6] Their technical findings should retain their research context when retold in everyday language.

For current cultivation questions, begin with USDA’s hemp program and then identify the relevant state or tribal authority.[7] For finished-product and care questions, follow the corresponding guides. Knowing which source can answer which question is as useful as knowing the word itself.

CBD Terms and Definitions

Absorption

The process by which a substance moves from its site of administration into the body. A study of absorption measures an exposure question, such as changing blood concentrations. That finding should remain distinct from a claim about symptom improvement. The formulation, route, and conditions of the experiment matter when interpreting it.

Adverse Event

An unwanted medical occurrence recorded during a study or after a product exposure. An event happening during treatment does not, by itself, prove that treatment caused it. Read how investigators assessed events and how often they occurred in comparison groups. Safety reporting is part of the study result, alongside any possible benefit.

Anandamide

An endocannabinoid produced within the body and investigated in cannabinoid-system research. Naming a signaling compound can help explain a biological hypothesis. It does not diagnose a deficiency in a reader or establish that a retail supplement corrects one. A mechanism claim needs to be separated from the clinical outcome being proposed.

Baseline

The starting measurement used in an analysis, often recorded before an intervention. A change from baseline tells you how that group changed over time. To understand the added effect of a treatment, also examine the comparison group and the planned analysis. Improvement from the starting point alone can leave the main question unanswered.

Batch Number

An identifier assigned to a production group. Match the actual package identifier with the lot or batch on the laboratory report, along with the product name and form. A similar brand name is a weaker match. A report for a different batch may provide background, but it does not test the bottle in your hand.

Bioavailability

The extent to which an administered substance reaches systemic circulation. This is an exposure concept, rather than a promise of clinical benefit. A listed container amount cannot tell you a person’s measured exposure on its own. Research findings need their particular formulation, route, meals, and participants kept beside the result.

Blinding or Masking

A study feature intended to keep participants, investigators, or assessors unaware of treatment assignments, depending on the design. Read who was masked and how. Masking helps limit influences on care and assessment, but a familiar-looking package does not demonstrate that it was effective. A paper should explain the actual procedure.

Broad-Spectrum

A common industry description for an extract containing multiple plant compounds with THC intended to be removed. The term alone does not establish the measured contents of the finished product. Review the batch report, its cannabinoid panel, and its reporting thresholds. Different formulas can use the same description while containing different amounts.

Cannabinoid

A term used for a family of compounds associated with cannabinoid biology, including CBD and THC. The individual compound name matters. A paper discussing cannabinoids may concern a particular medicine, a mixture, or a laboratory pathway. Identify the actual intervention before treating a broad cannabinoid result as a CBD-only finding.

Cannabidiol (CBD)

A cannabinoid found in cannabis. CBD itself does not produce the typical high associated with THC, but that statement does not identify every ingredient in a marketed CBD product. Read the entire formula and relevant measurements. The compound name also does not establish that a finished product improves a particular health condition.

Cannabis

The plant term used in discussions of hemp, cannabinoid extracts, and other cannabis products. A reference to cannabis in a research title does not specify a CBD-only preparation. The tested material may include THC or other compounds. Find the methods and composition before using the title to summarize the clinical result.

Carrier Oil

An oil used to carry or dilute another ingredient in a finished formula. MCT oil and hemp seed oil can appear in this role. A carrier name does not provide a CBD amount. Read the ingredient list together with the quantitative label and laboratory results to understand what the formula claims and what was measured.

Certificate of Analysis (COA)

A laboratory report describing measurements made on a particular sample. Check the sample identity, lot, dates, units, analytes, methods, and test scope. A report may cover cannabinoid content without covering every contaminant question. The document contributes evidence about its sample; it is not a clinical effectiveness study or a complete personal safety assessment.

Clinical Significance

The practical importance of a finding for health or daily life. A small numerical difference may be statistically detectable while leaving its practical value uncertain. Ask what changed, by how much, and whether participants gained a meaningful improvement in the outcome concerned. Read any thresholds and their justification in the actual study.

Clinical Trial

A study that assigns people to interventions to investigate health-related questions. Trials vary in design, comparison, size, and follow-up. The term alone does not tell you the strength or direction of the result. Identify the population, full intervention, planned outcomes, and findings before deciding which claim the experiment can support.

Concentration

The amount of a substance per unit of mass or volume, such as milligrams of CBD per milliliter of oil. Concentration differs from the total amount in a container. An illustrative bottle listing 900 mg in 30 mL has a listed concentration of 30 mg per mL. That arithmetic explains the figures without choosing a personal dose.

Confidence Interval

A range used to express uncertainty around an estimated quantity under a statistical model. Read the method and the outcome scale with the interval. A wide range can leave several plausible effect sizes unresolved. The interval does not remove the need to consider study design, missing data, bias, or practical importance.

Control Group

The group used as a comparison in a study. Depending on the design, it may receive placebo, usual care, or another intervention. Read what participants in both groups actually received. An added-treatment experiment answers a different question from a replacement experiment, even when the same active ingredient appears in each.

Decarboxylation

A chemical process that changes an acidic cannabinoid into its corresponding neutral form, such as CBDA into CBD. This terminology can help interpret processing descriptions and cannabinoid measurements. It is not, by itself, a quality or effectiveness claim. This glossary explains the concept and does not provide a home extraction or heating procedure.

Detection Limit

A method-related threshold describing the ability to distinguish a measured substance from background. Laboratories should explain their terminology and units. A result below a stated threshold does not establish absolute absence at every possible sensitivity. Keep the reporting limit attached to a result described as not detected, especially when assessing THC-related claims.

Dose

The amount of a substance administered in a treatment or experiment. A research dose describes the study conditions, and a prescription dose belongs to a clinician’s plan for that medicine. Neither a trial quantity nor a retail serving label assesses a reader’s complete history. The glossary explains language rather than setting personal use instructions.

Double-Blind

A masking description commonly used when two relevant parties are kept unaware of treatment assignment. The exact parties and procedures should be specified in the paper rather than assumed from the label. Read who knew the allocation, how products were matched, and whether circumstances might have revealed an assignment during the study.

Endocannabinoid

A compound produced within the body that participates in cannabinoid signaling. This distinguishes an endogenous signaling compound from a cannabinoid supplied by a plant-derived product. Understanding the term can clarify a mechanism discussion. It does not imply that everyone needs to add external cannabinoids or that an online claim can identify a clinical deficiency.

Endocannabinoid System

A name for components involved in cannabinoid signaling, including signaling molecules, receptors, and processes that make and break down those molecules. Research into this biology can generate clinical hypotheses. A description of the system should not be shortened into a conclusion that a particular supplement restores balance or treats an unspecified condition.

Entourage Effect

A term used for a proposed interaction among components of a cannabis preparation. A proposal about combined effects needs appropriate comparisons to establish a specific clinical claim. A mixture study alone may leave the contributions of its ingredients unresolved. The phrase on a product label does not quantify benefit, verify contents, or settle that research question.

Extract

Material obtained from a source such as plant tissue through a processing method. The word does not specify every compound, concentration, or contaminant measurement. An extract used as an ingredient can differ from the finished consumer formula. When reading a report, check which stage and sample were tested before applying its numbers to the package.

Food Effect

A change in measured drug exposure associated with a meal under the conditions of an experiment. A purified-CBD pharmacokinetic study can investigate this question directly. Its finding does not create a universal timing or use rule for all retail products. Preserve the meal, formulation, amount, and outcome when describing the research.

Full-Spectrum

A common description for CBD alongside other plant compounds, potentially including THC. Different products may use the phrase for different mixtures. Read actual cannabinoid measurements and complete ingredients rather than treating the spectrum term as a fixed formula. It does not establish superior clinical benefit or remove drug-testing and interaction questions.

Half-Life

A pharmacokinetic measure describing how long it takes the measured concentration to fall by half during an identified phase. The study conditions and model matter. Half-life is different from onset, peak concentration, or duration of a perceived effect. It cannot, by itself, establish when driving is safe or when a drug test will be negative.

Hemp

A cannabis classification with a legal definition applied by the relevant authority. The precise definition, effective date, and activity matter when answering compliance questions. A crop classification alone cannot settle every rule for a finished food, cosmetic, or other product. Use the current legal overview and official state sources for the actual situation.

Hemp Seed Oil

Oil obtained from hemp seeds, used as a food ingredient or as part of another formula. Its name is distinct from a measured CBD extract amount. A product may combine seed oil with a cannabinoid ingredient, so read both the formula and quantities. Do not infer a CBD concentration from the seed-oil name alone.

Isolate

A common description for CBD separated from other cannabinoids. It may describe an ingredient rather than the finished product. Added oils, flavors, or other active compounds still matter. The word alone does not certify a package, prove an absolute zero-THC result, or guarantee a particular outcome under a drug-testing policy.

Limit of Quantification

A threshold related to reliable numerical reporting for a method. It can differ from a detection threshold. A laboratory may recognize a substance while being unable to quantify it reliably below the stated limit. Read the report’s definitions rather than assuming every abbreviation means the same thing across different laboratories.

MCT Oil

Medium-chain triglyceride oil, a term for a category of oils that can serve as carriers in CBD formulas. The carrier does not establish the amount of CBD added to it. Read the cannabinoid amount and complete ingredient list separately. A comparison of carrier names is also different from evidence that a finished formulation improves a health outcome.

Milligram (mg)

A unit of mass. One gram equals 1,000 milligrams. A figure in milligrams may refer to CBD, an extract, a mixture, or another ingredient, so identify what is being weighed. Total milligrams per container and milligrams per serving answer different questions. A large front-label number needs the substance and quantity it describes.

Milliliter (mL)

A unit of volume. It is different from a milligram, which measures mass. Oil labels may use milliliters for bottle volume or a listed serving. To relate volume to a CBD mass, you need the concentration or the corresponding total-container figures. A drop count alone does not establish a universal measured milliliter amount.

Not Detected (ND)

A result below the laboratory’s stated detection or reporting threshold for the test performed. Read the threshold and units. ND differs from not tested, and it does not establish absolute absence at every sensitivity. If the report never measured the substance, the missing result cannot be read as a negative finding.

Observational Study

Research that observes exposures and outcomes without assigning the intervention in the same way as an experiment. It can describe patterns and generate useful questions. Other differences between people may influence the association. Read how researchers addressed those differences and avoid treating an observed relationship as a fully established causal effect.

Open-Label Study

A study in which treatment identity is known to relevant participants or investigators, rather than masked as in a blinded experiment. Such research can contribute feasibility, safety, or preliminary outcome information. Expectations and the absence of a suitable control may limit efficacy conclusions. Read the design alongside any reported improvement.

Placebo

A comparison intervention intended to lack the active treatment component under study. Its role is to help interpret what the active intervention added under the experiment’s conditions. Read its ingredients and whether masking was maintained. Improvement in a placebo group can have multiple influences, so the result is more informative than a simple claim that nothing happened.

Preclinical Research

Research conducted before or outside direct clinical testing in the relevant patients, often involving cells, tissues, or animal models. It can investigate mechanisms and guide later experiments. A preclinical result should retain its model and outcome. It does not, on its own, establish that a finished retail product treats the corresponding human condition.

Primary Outcome

The main outcome identified for a study’s central question. Its definition, analysis, and timing should be reported. Read that result before choosing favorable secondary or subgroup findings. Other outcomes can be valuable, but their role should stay visible. A positive exploratory measure does not automatically replace a negative primary comparison.

Randomized Trial

A trial that uses chance to assign participants to groups. Randomization helps reduce systematic starting differences, while other design features and follow-up still affect interpretation. Read the actual allocation, masking, sample size, and analysis. The randomized label is useful information, rather than a reason to accept every conclusion without examining the results.

Route of Administration

The way an intervention is given or used, such as oral, topical, or inhaled. Route belongs beside the study’s formulation and outcome. A result from one route cannot be automatically transferred to another product or exposure. A cream study, for example, needs its own formulation-specific interpretation rather than becoming a conclusion about swallowed oils.

Secondary Outcome

An additional outcome assessed beyond a study’s main planned question. Secondary results may provide context or guide future work. Read whether the analyses were planned, how many comparisons were made, and what uncertainty remains. A headline that selects one favorable measure should still explain the primary result and the rest of the study.

Serving Size

The amount a label uses to express a serving, such as a volume of oil or a number of gummies. It helps interpret listed quantities. It does not establish an appropriate personal dose, examine medical history, or account for interactions. Read serving arithmetic as label information, with personal decisions assessed separately.

Statistical Significance

A statistical assessment made under a specified method and threshold. It is different from the size or practical importance of a difference. A nonsignificant result can reflect uncertainty as well as an absence of a demonstrated effect. Read the estimate, interval, design, and outcome instead of reducing the analysis to a single threshold word.

THC

Tetrahydrocannabinol, with delta-9 THC commonly discussed as the cannabis compound principally associated with a high. A report should identify which THC-related analytes were measured. A CBD label does not establish their absence. THC-containing study findings and CBD-only study findings also need separate descriptions because the full intervention differs.

Total CBD on a Label

The CBD amount claimed for an entire container, rather than one milliliter or one listed serving. Divide by the relevant container quantity to understand the claimed concentration or amount per item. Check that the number refers to CBD specifically. An extract mass is a different figure and should not silently replace it.

Uncertainty

What remains unresolved about a measurement or conclusion. In a laboratory report, this may involve the method and numerical estimate. In a clinical study, it also involves design, sample, duration, and application to other settings. Naming uncertainty makes the explanation more precise; it does not automatically create evidence for the preferred alternative.